Accordingly, deletion of HIFs in myeloid cells decreases NASH progression while myeloid cell-specific HIF-1α or HIF-2α deletion impairs immune function. The gene discussed is HIF1A; the disease is metabolic dysfunction-associated steatohepatitis.